Today’s high-definition displays pack in the pixels to provide breathtaking color and detail. But another display technology, called high dynamic range (HDR), can produce far higher contrast, correctly and vividly displaying details of both the brightest and darkest areas within the same scene.
Study in contrast: A high-dynamic-range display renders bright and dark regions of the same image with great clarity. An image of a castle (bottom) simulates the improvement over what is possible with a conventional display (top).
Credit: Erik Reinhard
See examples of high-dynamic range images.
HDR products might be available soon; earlier this year, Dolby bought HDR-display maker BrightSide Technologies, of British Columbia. The company’s liquid-crystal-display prototypes are illuminated by arrays of tiny light-emitting diodes (LEDs); individual LEDs can be controlled, increasing the darkness or brightness of various parts of an image.
Just as high-def-display makers initially faced sluggish sales because most TV content wasn’t filmed in high definition, wasting their displays’ extra capacity, HDR-display makers have to contend with TV content that doesn’t capture high-contrast information.
But Ahmet Oguz Akyüz, Roland Fleming, and colleagues at the Max Planck Institute for Biological Cybernetics in Tübingen, Germany, have good news. They conducted perceptual experiments to show that when ordinary images are displayed on an HDR screen, simply enhancing their contrast–increasing the intensity of the brights and diminishing the intensity of the darks–mimics the HDR effect and produces pleasing results.
So even if your favorite show isn’t filmed to capture high contrast, you could soon be seeing it in a whole new light.
Meta has built a massive new language AI—and it’s giving it away for free
Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3
The gene-edited pig heart given to a dying patient was infected with a pig virus
The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.
Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.
Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.